Eurazeo Shares Fall 2.39% After a 8% Surge Over the Past Week
The investment company's stock loses over 2% this Monday in a downward trending Paris market. This decline comes after the stock had seen a nearly 8% increase over the past seven days, and just weeks before key dates in the group's financial calendar.
Current Session Overview
In today's session, Eurazeo is trading at around €46.87, down 2.39% compared to last Friday's close of €48.02. This movement is part of a challenging session for the Parisian market: the CAC 40 is down 1.11% during the session while the SBF 120 drops 1.06%. Other financial sector stocks are also experiencing losses, such as AXA (-1.13%) and Adyen (-1.64%). Technically, the stock is in the upper part of its Bollinger Bands, at 92% of the range defined by the upper bound (€47.83) and the lower bound (€35.84). This proximity to the upper bound signals a potential overbought zone, confirmed by an RSI at 70—a threshold typically associated with a short-term bullish excess. However, the price remains well above its 50-day moving average (€44.82), indicating a positive momentum over recent weeks, although the 200-day moving average (€52.79) reminds us that the underlying trend is still deteriorated, with an annual decline close to 20%.
Financial Calendar Highlights
Eurazeo's financial calendar is entering a busy phase. The general assembly is scheduled for May 6, followed by the publication of the first quarter 2026 revenue on May 13. These two events could provide increased visibility into the capital deployment strategy and recent operational performances of the portfolio. Later in the year, the semi-annual results are expected on July 23, followed by the revenue for the first nine months on November 5. It is noteworthy that the stock has a negative beta of -0.31, historically indicating a low correlation with overall market movements.
